SCHEMBL8091389

SCHEMBL8091389

CCCS(=O)(=O)NC(=O)Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.58
EPHX2 P34913 2/20 0.58
CYP3A4 P08684 1/20 0.55
CA2 P00918 2/20 0.54
CA9 Q16790 2/20 0.54
CA4 P22748 1/20 0.54
CA5A P35218 1/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
NPC1 O15118 1/20 0.53
LMNA P02545 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CHRM1 P11229 1/20 0.53
SLC6A2 P23975 1/20 0.53
PDE4A P27815 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRM1 P35372 1/20 0.53
HTT P42858 1/20 0.53
PDE3A Q14432 1/20 0.53
NLRP3 Q96P20 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8091384 0.84 KDR (0.64) EPHX2CA2CA9LMNAMAPT
SCHEMBL8091423 0.84 ALDH1A1 (0.53) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL8095034 0.78 EPHX1 (0.55) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL9413498 0.77 MEN1 (0.55) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL8083234 0.77 EPHX1 (0.62) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL11619645 0.76 KMT2A (0.76) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL30640703 0.76 EPHX1 (1.00) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL2683478 0.76 EPHX1 (1.00) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL8083314 0.75 ALDH1A1 (0.50) CA2CA9CA4MEN1KMT2A
SCHEMBL8091363 0.74 ALDH1A1 (0.49) CA2CA9MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed